Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)1263-1265
Number of pages3
JournalMultiple Sclerosis
Volume22
Issue number10
DOIs
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this